BackSAB Biotherapeutics- Warrants (25/07/2027) Overview

SAB Biotherapeutics- Warrants (25/07/2027) Current Assets

Latest current assets for SABSW: $110M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$107.74M
↓ 4.89% YoYΔ $-5.54M vs prior year quarter

Peer trimmed avg / median

Loading

SAB Biotherapeutics- Warrants (25/07/2027) Current Assets History

Loading

SAB Biotherapeutics- Warrants (25/07/2027) vs. peers: Current Assets Comparison

Loading

SAB Biotherapeutics- Warrants (25/07/2027) Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

SAB Biotherapeutics- Warrants (25/07/2027) (SABSW) FAQ

SAB Biotherapeutics- Warrants (25/07/2027) posts a current assets of $110M as of September 2026. That compares with $110M in the prior-year period — down 4.9% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, SAB Biotherapeutics- Warrants (25/07/2027)'s current assets was $110M. The latest reading is $110M — a 4.9% year-over-year decrease (period ending September 2026). Use the history and growth charts on this page for a longer lookback.

Current Assets is one piece of SAB Biotherapeutics- Warrants (25/07/2027)'s financial statement story. At $110M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for SABSW's current assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; SAB Biotherapeutics- Warrants (25/07/2027)'s other metric pages and overview cover the third.

Questions & Answers